A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment

BACKGROUND AND OBJECTIVES: A photochemical treatment process (PCT) utilizing amotosalen and UVA light (INTERCEPT™ Blood System) has been developed for inactivation of viruses, bacteria, parasites and leucocytes that can contaminate blood components intended for transfusion. The objective of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Knutson, F, Osselaer, J, Pierelli, L, Lozano, M, Cid, J, Tardivel, R, Garraud, O, Hervig, T, Domanovic, D, Cukjati, M, Gudmundson, S, Hjalmarsdottir, I B, Castrillo, A, Gonzalez, R, Brihante, D, Santos, M, Schlenke, P, Elliott, A, Lin, J-S, Tappe, D, Stassinopoulos, A, Green, J, Corash, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Transfusion Medicine and New Therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690512/
https://www.ncbi.nlm.nih.gov/pubmed/25981525
http://dx.doi.org/10.1111/vox.12287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690512/
https://www.ncbi.nlm.nih.gov/pubmed/25981525
http://dx.doi.org/10.1111/vox.12287

Ejemplares similares